Literature DB >> 17627820

Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.

Ann-Charlott Söderpalm1, Per Magnusson, Anne-Christine Ahlander, Jón Karlsson, Anna-Karin Kroksmark, Már Tulinius, Diana Swolin-Eide.   

Abstract

This cross-sectional study examined bone mineral density, bone turnover, body composition and calciotropic hormones in 24 boys with Duchenne muscular dystrophy (DMD) (2.3-19.7 years), most of whom were being treated with prednisolone, and 24 age-matched healthy boys. Our study demonstrated lower bone mineral density in the DMD group for total body, spine, hip, heel and forearm measurements. These differences between DMD patients and controls increased with increasing age. Biochemical markers of both bone formation and resorption revealed reduced bone turnover in DMD patients. The fracture rate was not higher in DMD patients. The DMD group had low vitamin D levels but high leptin levels in comparison with the control group. Muscle strength correlated with bone mineral density assessed at the hip and heel in the DMD group. Interventions that increase bone formation should be considered, as DMD patients have reduced bone turnover in addition to their low bone mineral density.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627820     DOI: 10.1016/j.nmd.2007.05.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  34 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.

Authors:  S A Novotny; G L Warren; A S Lin; R E Guldberg; K A Baltgalvis; D A Lowe
Journal:  J Musculoskelet Neuronal Interact       Date:  2012-03       Impact factor: 2.041

3.  Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Authors:  Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; William J Jusko; Panteleimon D Mavroudis; Benjamin D Schwartz; Laurel J Mengle-Gaw; Edward C Smith; Jean K Mah; Michela Guglieri; Yoram Nevo; Nancy Kuntz; Craig M McDonald; Mar Tulinius; Monique M Ryan; Richard Webster; Diana Castro; Richard S Finkel; Andrea L Smith; Lauren P Morgenroth; Adrienne Arrieta; Maya Shimony; Mark Jaros; Phil Shale; John M McCall; Yetrib Hathout; Kanneboyina Nagaraju; John van den Anker; Leanne M Ward; Alexandra Ahmet; Michaelyn R Cornish; Paula R Clemens
Journal:  Pharmacol Res       Date:  2018-09-13       Impact factor: 7.658

Review 4.  The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position.

Authors:  David R Weber; Alison Boyce; Catherine Gordon; Wolfgang Högler; Heidi H Kecskemethy; Madhusmita Misra; Diana Swolin-Eide; Peter Tebben; Leanne M Ward; Halley Wasserman; Christopher Shuhart; Babette S Zemel
Journal:  J Clin Densitom       Date:  2019-07-10       Impact factor: 2.617

Review 5.  Coaxing stem cells for skeletal muscle repair.

Authors:  Karl J A McCullagh; Rita C R Perlingeiro
Journal:  Adv Drug Deliv Rev       Date:  2014-07-15       Impact factor: 15.470

6.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

7.  Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.

Authors:  Y Guan; F Lv; Y Meng; D Ma; X Xu; Y Song; O Wang; Y Jiang; W Xia; X Xing; J Zhang; M Li
Journal:  Osteoporos Int       Date:  2017-04-24       Impact factor: 4.507

8.  Treatment and complications in flaccid neuromuscular scoliosis (Duchenne muscular dystrophy and spinal muscular atrophy) with posterior-only pedicle screw instrumentation.

Authors:  Hitesh N Modi; Seung-Woo Suh; Jae-Young Hong; Jae-Woo Cho; Jong-Hoon Park; Jae-Hyuk Yang
Journal:  Eur Spine J       Date:  2009-11-03       Impact factor: 3.134

9.  Musculoskeletal response of dystrophic mice to short term, low intensity, high frequency vibration.

Authors:  S A Novotny; M D Eckhoff; B C Eby; J A Call; D Nuckley; D A Lowe
Journal:  J Musculoskelet Neuronal Interact       Date:  2013-12       Impact factor: 2.041

10.  Vitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone health.

Authors:  Jennifer Aton; Rebecca Hurst Davis; Kristine C Jordan; Charles B Scott; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2013-01-17       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.